Status:
WITHDRAWN
Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique
Lead Sponsor:
Graydon Meneilly
Conditions:
Diabetes Mellitus
Lipohypertrophy
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
This study will use the euglycemic clamp technique to evaluate insulin absorption when insulin is administered subcutaneously in an area of subclinical lipohypertrophy vs an area of normal tissue.
Detailed Description
The use of insulin to manage diabetes can cause changes to the skin at sites where insulin is administered. These changes may be felt as lumps under the skin. Insulin injected into these areas may not...
Eligibility Criteria
Inclusion
- Participated in Glycemic Variability study
- Type 2 Diabetes for at least 2 years
- Currently using insulin to manage diabetes
- Have used insulin to manage diabetes for at least 2 years
- Age 19 or older
- BMI \< 30 kg/m2
- Confirmed areas of subclinical lipohypertrophic adipose tissue lesions via ultrasound
Exclusion
- Taking other injectable medications (eg liraglutide/Victoza
- Taking systemic steroids (ie prednisone)
- Severe renal insufficiency (eGFR \< 30 ml/min/1.73 m2
- Hypoglycemic unawareness
- Current pregnancy
- Not fluent in speaking and writing English (unless accompanied by a translator)
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 22 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03229850
Start Date
February 1 2021
End Date
April 22 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia - Gerontology Research Lab
Vancouver, British Columbia, Canada, V5Z 1M9